Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues.

Okudaira K, Kakar S, Cun L, Choi E, Wu Decamillis R, Miura S, Sleisenger MH, Kim YS, Deng G.

Int J Oncol. 2010 Apr;36(4):765-75.

PMID:
20198318
2.

EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers.

Karibe T, Fukui H, Sekikawa A, Shiratori K, Fujimori T.

J Pathol. 2008 Sep;216(1):32-42. doi: 10.1002/path.2377.

PMID:
18543267
3.

Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas.

Mesquita P, Peixoto AJ, Seruca R, Hanski C, Almeida R, Silva F, Reis C, David L.

Cancer Lett. 2003 Jan 28;189(2):129-36.

PMID:
12490305
4.

DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer.

Kato K, Maesawa C, Itabashi T, Fujisawa K, Otsuka K, Kanno S, Tada H, Tatemichi Y, Kotani K, Oikawa H, Sugai T, Wakabayashi G, Masuda T.

Int J Oncol. 2009 Sep;35(3):467-76.

PMID:
19639167
5.

Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.

Hamada T, Goto M, Tsutsumida H, Nomoto M, Higashi M, Sugai T, Nakamura S, Yonezawa S.

Cancer Lett. 2005 Sep 28;227(2):175-84. Epub 2005 Jan 18.

PMID:
16112420
6.

MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma.

Darwanto A, Kitazawa R, Maeda S, Kitazawa S.

Cancer Sci. 2003 May;94(5):442-7.

7.

Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.

Riojas MA, Guo M, Glöckner SC, Machida EO, Baylin SB, Ahuja N.

Cancer Biol Ther. 2007 Nov;6(11):1710-6. Epub 2007 Aug 3.

PMID:
17986858
8.

Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues.

Kim BN, Yamamoto H, Ikeda K, Damdinsuren B, Sugita Y, Ngan CY, Fujie Y, Ogawa M, Hata T, Ikeda M, Ohue M, Sekimoto M, Monden T, Matsuura N, Monden M.

Int J Oncol. 2005 May;26(5):1217-26.

PMID:
15809712
9.

Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.

Tong JD, Jiao NL, Wang YX, Zhang YW, Han F.

Neoplasma. 2011;58(5):441-8.

PMID:
21744999
10.

Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation.

Gratchev A, Siedow A, Bumke-Vogt C, Hummel M, Foss HD, Hanski ML, Kobalz U, Mann B, Lammert H, Mansmann U, Stein H, Riecken EO, Hanski C.

Cancer Lett. 2001 Jul 10;168(1):71-80. Erratum in: Cancer Lett 2002 Jan 10;175(1):107.

PMID:
11368880
11.

Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors.

Zheng S, Chen P, McMillan A, Lafuente A, Lafuente MJ, Ballesta A, Trias M, Wiencke JK.

Carcinogenesis. 2000 Nov;21(11):2057-64.

PMID:
11062168
12.

Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma.

Guo W, Dong Z, Chen Z, Yang Z, Wen D, Kuang G, Guo Y, Shan B.

Cancer Invest. 2009 May;27(4):459-65. doi: 10.1080/07357900802620828.

PMID:
19160099
13.

Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.

Ho JJ, Han SW, Pan PL, Deng G, Kuan SF, Kim YS.

Int J Oncol. 2003 Feb;22(2):273-9.

PMID:
12527922
14.

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.

J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131. Epub 2009 Jun 17.

PMID:
19535783
15.

MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation.

Hanski C, Riede E, Gratchev A, Foss HD, Böhm C, Klussmann E, Hummel M, Mann B, Buhr HJ, Stein H, Kim YS, Gum J, Riecken EO.

Lab Invest. 1997 Dec;77(6):685-95.

PMID:
9426407
16.

Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.

Umetani N, Takeuchi H, Fujimoto A, Shinozaki M, Bilchik AJ, Hoon DS.

Clin Cancer Res. 2004 Nov 15;10(22):7475-83.

17.

Aberrant expression and demethylation of gamma-synuclein in colorectal cancer, correlated with progression of the disease.

Ye Q, Zheng MH, Cai Q, Feng B, Chen XH, Yu BQ, Gao YB, Ji J, Lu AG, Li JW, Wang ML, Liu BY.

Cancer Sci. 2008 Oct;99(10):1924-32. doi: 10.1111/j.1349-7006.2008.00947.x.

18.

Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.

Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, Toyota M, Ouchida M, Aoe M, Date H, Pass HI, Doihara H, Shimizu N.

Oncol Rep. 2004 Nov;12(5):1087-92.

PMID:
15492797
19.

Promoter CpG methylation of caveolin-1 in sporadic colorectal cancer.

Lin SY, Yeh KT, Chen WT, Chen HC, Chen ST, Chang JG.

Anticancer Res. 2004 May-Jun;24(3a):1645-50.

20.

The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.

Burger-van Paassen N, Vincent A, Puiman PJ, van der Sluis M, Bouma J, Boehm G, van Goudoever JB, van Seuningen I, Renes IB.

Biochem J. 2009 May 13;420(2):211-9. doi: 10.1042/BJ20082222.

PMID:
19228118

Supplemental Content

Support Center